Global Immune Checkpoint Proteins Market Growth 2024-2030

Publication ID:

LPI11242630

Publication Date:

November 19, 2024

Pages:

110

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Immune checkpoint proteins are molecules found on the surface of immune cells, that play a crucial role in regulating the immune system. These proteins help maintain the balance between immune activation and immune tolerance, preventing the immune system from attacking normal cells and tissues in the body. However, their role can be subverted by cancer cells to evade immune detection. Targeting these proteins with immune checkpoint inhibitors has become a powerful strategy in cancer treatment, offering new hope for patients with various types of cancer.
The global Immune Checkpoint Proteins market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淚mmune Checkpoint Proteins Industry Forecast鈥� looks at past sales and reviews total world Immune Checkpoint Proteins sales in 2023, providing a comprehensive analysis by region and market sector of projected Immune Checkpoint Proteins sales for 2024 through 2030. With Immune Checkpoint Proteins sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immune Checkpoint Proteins industry.
This Insight Report provides a comprehensive analysis of the global Immune Checkpoint Proteins landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immune Checkpoint Proteins portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Immune Checkpoint Proteins market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immune Checkpoint Proteins and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immune Checkpoint Proteins.
United States market for Immune Checkpoint Proteins is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Immune Checkpoint Proteins is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Immune Checkpoint Proteins is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Immune Checkpoint Proteins players cover MedChemExpress, Bio-Techne, ProteoGenix, Creative BioMart, GenScript, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Immune Checkpoint Proteins market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Immune Checkpoint Inhibitory Proteins
Immune Checkpoint Stimulatory Proteins
Segmentation by Application:
Cancer Immunotherapy
Autoimmune Disease Treatment
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
MedChemExpress
Bio-Techne
ProteoGenix
Creative BioMart
GenScript
Bio X Cell
KACTUS
DIMA Biotechnology
Creative Biolabs
Leinco Technologies
ACROBiosystems
Elabscience
ProbeChem
Sino Biological
Key Questions Addressed in this Report
What is the 10-year outlook for the global Immune Checkpoint Proteins market?
What factors are driving Immune Checkpoint Proteins market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Immune Checkpoint Proteins market opportunities vary by end market size?
How does Immune Checkpoint Proteins break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Immune Checkpoint Proteins Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Immune Checkpoint Proteins by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Immune Checkpoint Proteins by Country/Region, 2019, 2023 & 2030
2.2 Immune Checkpoint Proteins Segment by Type
2.2.1 Immune Checkpoint Inhibitory Proteins
2.2.2 Immune Checkpoint Stimulatory Proteins
2.3 Immune Checkpoint Proteins Sales by Type
2.3.1 Global Immune Checkpoint Proteins Sales Market Share by Type (2019-2024)
2.3.2 Global Immune Checkpoint Proteins Revenue and Market Share by Type (2019-2024)
2.3.3 Global Immune Checkpoint Proteins Sale Price by Type (2019-2024)
2.4 Immune Checkpoint Proteins Segment by Application
2.4.1 Cancer Immunotherapy
2.4.2 Autoimmune Disease Treatment
2.4.3 Others
2.5 Immune Checkpoint Proteins Sales by Application
2.5.1 Global Immune Checkpoint Proteins Sale Market Share by Application (2019-2024)
2.5.2 Global Immune Checkpoint Proteins Revenue and Market Share by Application (2019-2024)
2.5.3 Global Immune Checkpoint Proteins Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Immune Checkpoint Proteins Breakdown Data by Company
3.1.1 Global Immune Checkpoint Proteins Annual Sales by Company (2019-2024)
3.1.2 Global Immune Checkpoint Proteins Sales Market Share by Company (2019-2024)
3.2 Global Immune Checkpoint Proteins Annual Revenue by Company (2019-2024)
3.2.1 Global Immune Checkpoint Proteins Revenue by Company (2019-2024)
3.2.2 Global Immune Checkpoint Proteins Revenue Market Share by Company (2019-2024)
3.3 Global Immune Checkpoint Proteins Sale Price by Company
3.4 Key Manufacturers Immune Checkpoint Proteins Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Immune Checkpoint Proteins Product Location Distribution
3.4.2 Players Immune Checkpoint Proteins Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Immune Checkpoint Proteins by Geographic Region
4.1 World Historic Immune Checkpoint Proteins Market Size by Geographic Region (2019-2024)
4.1.1 Global Immune Checkpoint Proteins Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Immune Checkpoint Proteins Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Immune Checkpoint Proteins Market Size by Country/Region (2019-2024)
4.2.1 Global Immune Checkpoint Proteins Annual Sales by Country/Region (2019-2024)
4.2.2 Global Immune Checkpoint Proteins Annual Revenue by Country/Region (2019-2024)
4.3 Americas Immune Checkpoint Proteins Sales Growth
4.4 APAC Immune Checkpoint Proteins Sales Growth
4.5 Europe Immune Checkpoint Proteins Sales Growth
4.6 Middle East & Africa Immune Checkpoint Proteins Sales Growth
5 Americas
5.1 Americas Immune Checkpoint Proteins Sales by Country
5.1.1 Americas Immune Checkpoint Proteins Sales by Country (2019-2024)
5.1.2 Americas Immune Checkpoint Proteins Revenue by Country (2019-2024)
5.2 Americas Immune Checkpoint Proteins Sales by Type (2019-2024)
5.3 Americas Immune Checkpoint Proteins Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immune Checkpoint Proteins Sales by Region
6.1.1 APAC Immune Checkpoint Proteins Sales by Region (2019-2024)
6.1.2 APAC Immune Checkpoint Proteins Revenue by Region (2019-2024)
6.2 APAC Immune Checkpoint Proteins Sales by Type (2019-2024)
6.3 APAC Immune Checkpoint Proteins Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Immune Checkpoint Proteins by Country
7.1.1 Europe Immune Checkpoint Proteins Sales by Country (2019-2024)
7.1.2 Europe Immune Checkpoint Proteins Revenue by Country (2019-2024)
7.2 Europe Immune Checkpoint Proteins Sales by Type (2019-2024)
7.3 Europe Immune Checkpoint Proteins Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Immune Checkpoint Proteins by Country
8.1.1 Middle East & Africa Immune Checkpoint Proteins Sales by Country (2019-2024)
8.1.2 Middle East & Africa Immune Checkpoint Proteins Revenue by Country (2019-2024)
8.2 Middle East & Africa Immune Checkpoint Proteins Sales by Type (2019-2024)
8.3 Middle East & Africa Immune Checkpoint Proteins Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Immune Checkpoint Proteins
10.3 Manufacturing Process Analysis of Immune Checkpoint Proteins
10.4 Industry Chain Structure of Immune Checkpoint Proteins
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Immune Checkpoint Proteins Distributors
11.3 Immune Checkpoint Proteins Customer
12 World Forecast Review for Immune Checkpoint Proteins by Geographic Region
12.1 Global Immune Checkpoint Proteins Market Size Forecast by Region
12.1.1 Global Immune Checkpoint Proteins Forecast by Region (2025-2030)
12.1.2 Global Immune Checkpoint Proteins Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Immune Checkpoint Proteins Forecast by Type (2025-2030)
12.7 Global Immune Checkpoint Proteins Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 MedChemExpress
13.1.1 MedChemExpress Company Information
13.1.2 MedChemExpress Immune Checkpoint Proteins Product Portfolios and Specifications
13.1.3 MedChemExpress Immune Checkpoint Proteins Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 MedChemExpress Main Business Overview
13.1.5 MedChemExpress Latest Developments
13.2 Bio-Techne
13.2.1 Bio-Techne Company Information
13.2.2 Bio-Techne Immune Checkpoint Proteins Product Portfolios and Specifications
13.2.3 Bio-Techne Immune Checkpoint Proteins Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bio-Techne Main Business Overview
13.2.5 Bio-Techne Latest Developments
13.3 ProteoGenix
13.3.1 ProteoGenix Company Information
13.3.2 ProteoGenix Immune Checkpoint Proteins Product Portfolios and Specifications
13.3.3 ProteoGenix Immune Checkpoint Proteins Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 ProteoGenix Main Business Overview
13.3.5 ProteoGenix Latest Developments
13.4 Creative BioMart
13.4.1 Creative BioMart Company Information
13.4.2 Creative BioMart Immune Checkpoint Proteins Product Portfolios and Specifications
13.4.3 Creative BioMart Immune Checkpoint Proteins Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Creative BioMart Main Business Overview
13.4.5 Creative BioMart Latest Developments
13.5 GenScript
13.5.1 GenScript Company Information
13.5.2 GenScript Immune Checkpoint Proteins Product Portfolios and Specifications
13.5.3 GenScript Immune Checkpoint Proteins Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 GenScript Main Business Overview
13.5.5 GenScript Latest Developments
13.6 Bio X Cell
13.6.1 Bio X Cell Company Information
13.6.2 Bio X Cell Immune Checkpoint Proteins Product Portfolios and Specifications
13.6.3 Bio X Cell Immune Checkpoint Proteins Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Bio X Cell Main Business Overview
13.6.5 Bio X Cell Latest Developments
13.7 KACTUS
13.7.1 KACTUS Company Information
13.7.2 KACTUS Immune Checkpoint Proteins Product Portfolios and Specifications
13.7.3 KACTUS Immune Checkpoint Proteins Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 KACTUS Main Business Overview
13.7.5 KACTUS Latest Developments
13.8 DIMA Biotechnology
13.8.1 DIMA Biotechnology Company Information
13.8.2 DIMA Biotechnology Immune Checkpoint Proteins Product Portfolios and Specifications
13.8.3 DIMA Biotechnology Immune Checkpoint Proteins Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 DIMA Biotechnology Main Business Overview
13.8.5 DIMA Biotechnology Latest Developments
13.9 Creative Biolabs
13.9.1 Creative Biolabs Company Information
13.9.2 Creative Biolabs Immune Checkpoint Proteins Product Portfolios and Specifications
13.9.3 Creative Biolabs Immune Checkpoint Proteins Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Creative Biolabs Main Business Overview
13.9.5 Creative Biolabs Latest Developments
13.10 Leinco Technologies
13.10.1 Leinco Technologies Company Information
13.10.2 Leinco Technologies Immune Checkpoint Proteins Product Portfolios and Specifications
13.10.3 Leinco Technologies Immune Checkpoint Proteins Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Leinco Technologies Main Business Overview
13.10.5 Leinco Technologies Latest Developments
13.11 ACROBiosystems
13.11.1 ACROBiosystems Company Information
13.11.2 ACROBiosystems Immune Checkpoint Proteins Product Portfolios and Specifications
13.11.3 ACROBiosystems Immune Checkpoint Proteins Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 ACROBiosystems Main Business Overview
13.11.5 ACROBiosystems Latest Developments
13.12 Elabscience
13.12.1 Elabscience Company Information
13.12.2 Elabscience Immune Checkpoint Proteins Product Portfolios and Specifications
13.12.3 Elabscience Immune Checkpoint Proteins Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Elabscience Main Business Overview
13.12.5 Elabscience Latest Developments
13.13 ProbeChem
13.13.1 ProbeChem Company Information
13.13.2 ProbeChem Immune Checkpoint Proteins Product Portfolios and Specifications
13.13.3 ProbeChem Immune Checkpoint Proteins Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 ProbeChem Main Business Overview
13.13.5 ProbeChem Latest Developments
13.14 Sino Biological
13.14.1 Sino Biological Company Information
13.14.2 Sino Biological Immune Checkpoint Proteins Product Portfolios and Specifications
13.14.3 Sino Biological Immune Checkpoint Proteins Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Sino Biological Main Business Overview
13.14.5 Sino Biological Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂